Cargando…
Virtual Infection Prevention and Control in Low- and Middle-Income Countries
COVID-19 brought new challenges and opportunities for infection prevention and control. Virtual infection prevention and control (VIPC), although nascent, is rapidly becoming a viable and necessary strategy for combatting the COVID-19 pandemic. Benefits of VIPC include extending the impact of global...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806406/ https://www.ncbi.nlm.nih.gov/pubmed/35121123 http://dx.doi.org/10.1016/j.ijid.2022.01.065 |
_version_ | 1784643437946994688 |
---|---|
author | Jones, Tristan Marimuthu, Kalisvar Bearman, Gonzalo |
author_facet | Jones, Tristan Marimuthu, Kalisvar Bearman, Gonzalo |
author_sort | Jones, Tristan |
collection | PubMed |
description | COVID-19 brought new challenges and opportunities for infection prevention and control. Virtual infection prevention and control (VIPC), although nascent, is rapidly becoming a viable and necessary strategy for combatting the COVID-19 pandemic. Benefits of VIPC include extending the impact of globally scarce infectious disease providers and public health practitioners, allowing coordination between disparate professionals to more effectively combat infectious disease, and increasing access to and quality of healthcare. Although mainly applied in developed countries, VIPC may play its greatest role in low- and middle-income countries (LMICs) with fewer healthcare resources. We conducted a brief literature search of VIPC in LMICs and found that many studies describe solutions in developed countries or describe planned or theoretical solutions. Few studies describe actual VIPC implementation in LMICs, except for China. Literature from related fields, for example, virtual critical care, and from developed countries is more robust and provides a roadmap for future research on VIPC in LMICs. Further research into strategies and outcomes related to VIPC in LMICs is necessary. |
format | Online Article Text |
id | pubmed-8806406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88064062022-02-02 Virtual Infection Prevention and Control in Low- and Middle-Income Countries Jones, Tristan Marimuthu, Kalisvar Bearman, Gonzalo Int J Infect Dis Review COVID-19 brought new challenges and opportunities for infection prevention and control. Virtual infection prevention and control (VIPC), although nascent, is rapidly becoming a viable and necessary strategy for combatting the COVID-19 pandemic. Benefits of VIPC include extending the impact of globally scarce infectious disease providers and public health practitioners, allowing coordination between disparate professionals to more effectively combat infectious disease, and increasing access to and quality of healthcare. Although mainly applied in developed countries, VIPC may play its greatest role in low- and middle-income countries (LMICs) with fewer healthcare resources. We conducted a brief literature search of VIPC in LMICs and found that many studies describe solutions in developed countries or describe planned or theoretical solutions. Few studies describe actual VIPC implementation in LMICs, except for China. Literature from related fields, for example, virtual critical care, and from developed countries is more robust and provides a roadmap for future research on VIPC in LMICs. Further research into strategies and outcomes related to VIPC in LMICs is necessary. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-04 2022-02-01 /pmc/articles/PMC8806406/ /pubmed/35121123 http://dx.doi.org/10.1016/j.ijid.2022.01.065 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Jones, Tristan Marimuthu, Kalisvar Bearman, Gonzalo Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title | Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title_full | Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title_fullStr | Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title_full_unstemmed | Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title_short | Virtual Infection Prevention and Control in Low- and Middle-Income Countries |
title_sort | virtual infection prevention and control in low- and middle-income countries |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806406/ https://www.ncbi.nlm.nih.gov/pubmed/35121123 http://dx.doi.org/10.1016/j.ijid.2022.01.065 |
work_keys_str_mv | AT jonestristan virtualinfectionpreventionandcontrolinlowandmiddleincomecountries AT marimuthukalisvar virtualinfectionpreventionandcontrolinlowandmiddleincomecountries AT bearmangonzalo virtualinfectionpreventionandcontrolinlowandmiddleincomecountries |